Beginning in 2015, Pneuma Respiratory set out to develop nanomist inhalers for smoking cessation and treating lung disorders designed with safety in mind. Pneuma's inhalers are intelligent having an Iot platform that incorporates geo-fencing for preventing use on prohibited grounds as well as integrated biometrics to keep their devices out of the wrong hands.
| Loading Documents... |
